Literature DB >> 18093358

Altered endothelial function following the Fontan procedure.

Maria A Binotto1, Nair Y Maeda, Antonio A Lopes.   

Abstract

OBJECTIVE: Thrombosis has been widely described after the Fontan procedure. The vascular endothelium plays a central role in the control of coagulation and fibrinolysis. The aim of this study was to investigate if patients undergoing a modified Fontan procedure have impaired endothelial function and fibrinolysis in the late postoperative course. PATIENTS AND METHODS: We compared 23 patients aged from 7 to 26 years with age-matched healthy volunteers, collecting blood samples prior to and following standardized venous occlusion testing. Plasma levels of von Willebrand factor antigen, tissue-type plasminogen activator antigen, plasminogen activator inhibitor-1, and D-dimer were measured with enzyme-linked immunosorbent assay.
RESULTS: We found increased plasma levels of von Willebrand factor antigen in patients when compared to controls (p = 0.003). At the basal condition, concentrations of tissue-type plasminogen activator antigen and plasminogen activator inhibitor-1 antigen in the plasma, as well as their activity, were not significantly different between patients and controls. Following venous occlusion, concentrations of tissue-type plasminogen activator antigen in the plasma were significantly increased both in patients and controls, compared to pre-occlusion values. D-dimer was within the reference range. Multivariate discriminant analysis differentiated patients and their controls on the basis of differences for plasminogen activator inhibitor-1 and von Willebrand factor antigen (p = 0.0016).
CONCLUSIONS: Our data suggest that patients with the Fontan circulation may have endothelial dysfunction, as indicated by raised levels of von Willebrand factor. Fibrinolysis seems to be relatively preserved, as suggested by appropriate response to venous occlusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18093358     DOI: 10.1017/S1047951107001680

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  16 in total

Review 1.  The Miracle Baby Grows Up: Hypoplastic Left Heart Syndrome in the Adult.

Authors:  Matthew Lewis; Marlon Rosenbaum
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 2.  Thromboembolic complications in adult congenital heart disease: the knowns and the unknowns.

Authors:  Magalie Ladouceur; Clément Karsenty; Victor Waldmann; Barbara Mulder; Sébastien Hascoet
Journal:  Clin Res Cardiol       Date:  2020-10-09       Impact factor: 5.460

3.  Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.

Authors:  L Idorn; A S Jensen; K Juul; J I Reimers; P I Johansson; K E Sørensen; S R Ostrowski; L Søndergaard
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

4.  Effect of Sildenafil on Pressure-Volume Loop Measures of Ventricular Function in Fontan Patients.

Authors:  Ryan J Butts; Shahryar M Chowdhury; George H Baker; Varsha Bandisode; Andrew J Savage; Andrew M Atz
Journal:  Pediatr Cardiol       Date:  2015-09-26       Impact factor: 1.655

5.  Impact of spironolactone on endothelial function in patients with single ventricle heart.

Authors:  William T Mahle; Alicia Wang; Arshed A Quyyumi; Michael E McConnell; Wendy M Book
Journal:  Congenit Heart Dis       Date:  2009 Jan-Feb       Impact factor: 2.007

6.  Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease.

Authors:  Alexander C Egbe; Heidi M Connolly; William R Miranda; Naser M Ammash; Donald J Hagler; Gruschen R Veldtman; Barry A Borlaug
Journal:  Circ Heart Fail       Date:  2017-12       Impact factor: 8.790

7.  Intermediate term thrombotic risk in contemporary total cavo-pulmonary connection for single ventricle circulations.

Authors:  Jenna M Faircloth; Olivia Roe; Tarek Alsaied; Joseph S Palumbo; Alexander Vinks; Gruschen R Veldtman
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

8.  Venous congestion and pulmonary vascular function in Fontan circulation: Implications for prognosis and treatment.

Authors:  Alexander C Egbe; Yogesh N V Reddy; Arooj R Khan; Mohamad Al-Otaibi; Emmanuel Akintoye; Masaru Obokata; Barry A Borlaug
Journal:  Int J Cardiol       Date:  2018-11-15       Impact factor: 4.164

9.  Hemodynamic and Clinical Implications of Impaired Pulmonary Vascular Reserve in the Fontan Circulation.

Authors:  Alexander C Egbe; William R Miranda; Jason H Anderson; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2020-12-08       Impact factor: 27.203

10.  Associations Between Blood Biomarkers, Cardiac Function, and Adverse Outcome in a Young Fontan Cohort.

Authors:  Eva van den Bosch; Sjoerd S M Bossers; Vivian P Kamphuis; Eric Boersma; Jolien W Roos-Hesselink; Johannes M P J Breur; Arend D J Ten Harkel; Livia Kapusta; Beatrijs Bartelds; Arno A W Roest; Irene M Kuipers; Nico A Blom; Laurens P Koopman; Willem A Helbing
Journal:  J Am Heart Assoc       Date:  2021-02-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.